ID   Hepd-uvBLMr
AC   CVCL_F0BG
RX   PubMed=2450630;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_22907; Bleomycin.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F0BF ! Hepd
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   PubMed=2450630; DOI=10.1002/1097-0142(19880415)61:8<1501::AID-CNCR2820610805>3.0.CO;2-4;
RA   Urade, Masahiro
RA   Sugi, Masakazu
RA   Miyazaki, Tadashi
RT   "Establishment of three bleomycin-resistant human carcinoma cell lines
RT   and their cross-resistance to other antitumor agents.";
RL   Cancer 61:1501-1507(1988).
//